Advanced breast cancer with pancreatic metastasis responded well to TKIs after ADC failure: A rare case report

Asian J Surg. 2024 Aug 23:S1015-9584(24)01766-4. doi: 10.1016/j.asjsur.2024.08.028. Online ahead of print.
No abstract available

Keywords: Anti-HER2 therapy; Breast cancer; Pancreatic metastasis; Tyrosine kinase inhibitors (TKIs).

Publication types

  • Letter